UDI: Value Beyond Compliance
In this informational session, Karen Conway discusses her research with the FDA on value and the UDI. Mike Schiller joins the conversation by adding the actions AHRMM is taking with the Learning UDI Community to identify adoption practices and move beyond compliance.
Related Resources
Letter/Comment
An announcement of the Final Rule issued by the IRS.
Advisory
The Food and Drug Administration (FDA) UDI system is being phased in over several years.
The AHRMM Cost, Quality, and Outcomes (CQO) Movement frames the critical role supply chain professionals play in driving high quality care, at a more…